Bladder trigone cancer
disease diseaseOn this page
Also known as cancer of trigone of urinary bladdermalignant neoplasm of trigone of urinary bladdermalignant trigone of urinary bladder neoplasmtrigone of urinary bladder cancer
Summary
Bladder trigone cancer (MONDO:0001375) is a cancer. A subtype of bladder dome cancer — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | bladder trigone cancer |
| Mondo ID | MONDO:0001375 |
| DOID | DOID:11813 |
| SNOMED CT | 188239000 |
| UMLS | C0496826 |
| MedGen | 635606 |
| Anatomy (UBERON) | UBERON:0001257 |
| Is cancer (heuristic) | yes |
Also known as: cancer of trigone of urinary bladder · malignant neoplasm of trigone of urinary bladder · malignant trigone of urinary bladder neoplasm · trigone of urinary bladder cancer
Disease family
This is a subtype of bladder dome cancer. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › urinary system disorder › urinary bladder disorder › urinary bladder neoplasm › urinary bladder cancer › bladder dome cancer › bladder trigone cancer
Related subtypes (1): ureteric orifice cancer
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.